Clinical trial
Testosterone in Female Hypoactive Sexual Desire Disorder
NCT00140153 · Beersheva Mental Health Center, Other · Completed
Key facts
| NCT number | NCT00140153 |
|---|---|
| Title | Testosterone in Female Hypoactive Sexual Desire Disorder |
| Official title | Transdermal Testosterone Gel Prn Application for Hypoactive Sexual Desire Disorder in Women: A Controlled Study |
| Lead sponsor | Beersheva Mental Health Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypoactive Sexual Desire Disorder |
| Intervention type | Drug |
| Interventions | testosterone gel (Androgel) |
| Enrollment | 20 |
| Start date | Apr 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Sep 1, 2005 |
| Last update posted | Nov 25, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: